Tobam has filed its 13F form on August 01, 2024 for Q2 2024 where it was disclosed a total value porftolio of $638 Million distributed in 326 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $20.1M, At&T Inc. with a value of $19.1M, United Therapeutics Corp with a value of $17.9M, Humana Inc with a value of $16.9M, and Mckesson Corp with a value of $16.7M.

Below you can find more details about Tobam portfolio as well as his latest detailed transactions.

Portfolio value $638 Million
Healthcare: $196 Million
Consumer Defensive: $130 Million
Technology: $91.2 Million
Financial Services: $65.2 Million
Communication Services: $59 Million
Consumer Cyclical: $28.8 Million
Basic Materials: $19.2 Million
Industrials: $17.8 Million
Other: $16.8 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 326
  • Current Value $638 Million
  • Prior Value $638 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 01, 2024
  • Form Type 13F-HR/A
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.